Healthcare
Neuroscientists Develop RADICAL: A Breakthrough Tool for Precise Neural Control
Researchers have engineered a novel chemogenetic tool called RADICAL that enables non-invasive, precise manipulation of brain activity using a synthetic chemical, offering significant potential for neuroscience research and therapeutic interventions.
Adageis Leverages AI to Transform Healthcare Revenue Forecasting and Patient Care
Adageis introduces an AI-powered ProActive Care Platform designed to help healthcare providers navigate value-based care models by improving clinical outcomes and revenue prediction through advanced predictive analytics.
Swedish Study Reveals Potential Neurological Connection Between Autism and Parkinson's Disease
A groundbreaking research from Karolinska Institutet suggests a significant biological link between autism spectrum disorder and Parkinson's disease, potentially opening new avenues for understanding neurodegenerative conditions.
AI-Powered Exoskeleton Restores Mobility for Wheelchair Users
A new AI-driven exoskeleton technology is transforming the lives of individuals with mobility impairments, offering unprecedented freedom and social interaction for wheelchair users through advanced technological innovation.
Lantern Pharma Shows Promise in Pediatric Brain Cancer Treatment
Lantern Pharma's experimental drug LP-184 demonstrates significant potential in treating atypical teratoid rhabdoid tumors (ATRT), a rare and aggressive pediatric brain cancer, with preclinical studies showing remarkable improvements in survival rates.
Scinai Immunotherapeutics Reports Revenue Growth and Narrowing Losses in Q1 2025
Scinai Immunotherapeutics demonstrates financial resilience with increased revenue from CDMO contracts and reduced net losses, signaling potential strategic pivots in its business model.
Kaged Unveils Pre-Workout MAX: A New Era in Sports Nutrition Performance
Kaged launches Pre-Workout MAX, a scientifically advanced supplement featuring innovative ingredients like MAXCatalyst™ and TriBsyn™, targeting athletes seeking enhanced performance with cleaner, more efficient nutrition.
Advocacy Group Supports Legislation to Enhance Early Childhood Vision Services
The American Council of the Blind endorses two bipartisan bills aimed at improving vision screenings and support for children with vision impairments, emphasizing the critical importance of early detection and intervention.
Alzamend Neuro Advances Innovative Therapies for Mental Health Disorders
Alzamend Neuro is developing novel therapeutic approaches for challenging neurological and psychiatric conditions, including Alzheimer's, Bipolar Disorder, Major Depressive Disorder, and PTSD. The company's pioneering treatments aim to improve patient outcomes by addressing current treatment limitations.
Telomir Pharmaceuticals Reveals Promising Vision Restoration in Preclinical AMD Study
Telomir Pharmaceuticals has demonstrated its oral therapeutic candidate Telomir-1 can restore vision and reverse retinal degeneration in a zebrafish model of age-related macular degeneration, highlighting potential breakthrough treatment for vision loss.
American Heart Association Urges Summer Safety Through CPR Preparedness
The American Heart Association highlights critical steps for summer safety, focusing on CPR training and heart health amid increased cardiac arrest risks when traditional support networks are less available.
University of Houston Receives $3M Grant to Advance Cancer Immunotherapy Research
The Texas Cancer Prevention & Research Institute awarded the University of Houston $3 million to establish a biomarker core, potentially transforming cancer research and patient outcomes through advanced immunotherapy techniques.
SeaStar Medical Expands Acute Kidney Injury Treatment Strategy with Promising Q1 Performance
SeaStar Medical reports significant growth in pediatric acute kidney injury treatment QUELIMMUNE and advances plans to enter the larger adult market, with potential to address a $4.5 billion annual opportunity.
Alzamend Neuro Launches Phase II Trial for Innovative Lithium-Based Alzheimer's Therapy
Alzamend Neuro has initiated a Phase II clinical trial for AL001, a novel lithium therapy targeting multiple neuropsychiatric conditions, with potential to improve brain drug delivery and reduce side effects.
Senate Bipartisan Initiative Aims to Revitalize U.S. Vaccine Manufacturing Capabilities
GeoVax Labs supports a Senate initiative to onshore critical medical manufacturing, highlighting the national push to rebuild domestic vaccine production and enhance public health preparedness through innovative MVA vaccine platforms.
Glucotrack Unveils Revolutionary Continuous Blood Glucose Monitor Technology at Upcoming Webinar
Glucotrack is set to showcase its innovative Continuous Blood Glucose Monitor (CBGM) technology, offering a potential breakthrough in diabetes management with longer-lasting, real-time monitoring capabilities.
RNA Pioneer Dr. Phillip Zamore Joins TransCode Therapeutics' Scientific Advisory Board
TransCode Therapeutics has appointed Dr. Phillip D. Zamore, a leading RNAi researcher, to its Scientific Advisory Board, potentially strengthening the company's oncology research capabilities and RNA therapeutic development strategies.
Breakthrough Stem Cell Dog Chews Show Promising Results in Veterinary Trials
Bioadaptives Inc's PawPa division has developed Regen Dog Chews that demonstrate significant potential for improving canine health through natural stem cell stimulation, with clinical trials showing a dramatic increase in circulating stem cells.
RNAi Pioneer Phillip Zamore Joins TransCode Therapeutics' Scientific Advisory Board
TransCode Therapeutics has added renowned RNA biology expert Dr. Phillip D. Zamore to its Scientific Advisory Board, potentially strengthening the company's RNA-targeted cancer therapy research and development strategy.
House Passes Budget Reconciliation Bill with Narrow Margin, Signaling Potential Healthcare Shifts
The U.S. House of Representatives has approved the 2025 budget reconciliation bill by a single vote, potentially introducing significant changes to health insurance and Medicaid. The legislation now moves to the Senate, where further modifications are expected.
RNAi Pioneer Dr. Phillip Zamore Joins TransCode Therapeutics' Scientific Advisory Board
TransCode Therapeutics strengthens its scientific leadership by appointing renowned RNA interference expert Dr. Phillip Zamore to its Scientific Advisory Board, potentially boosting the company's cancer therapeutic research capabilities.
NanoViricides Reveals Breakthrough Antiviral Platform at BIO International Convention
NanoViricides will showcase its novel NV-387 broad-spectrum antiviral drug candidate, which demonstrates promising preclinical efficacy against multiple viral infections, potentially revolutionizing viral treatment approaches.
Quantum BioPharma Advances Clinical Trial for MCAS Pain Treatment
Quantum BioPharma has received Australian ethics approval for a Phase 2 clinical trial of FSD202, a potential treatment for chronic pain associated with Mast Cell Activation Syndrome (MCAS), signaling progress in addressing a challenging medical condition.
Oragenics Implements 1-for-30 Reverse Stock Split to Enhance Market Appeal
Biotechnology company Oragenics will execute a reverse stock split to improve its capital markets positioning and potentially attract long-term investors, consolidating 30 existing shares into one new share.
Healthcare Triangle Secures Major Health System Contracts, Expands AI-Powered EHR Services
Healthcare Triangle has secured approximately $1.0 million in multi-year strategic contracts with top-tier healthcare systems and is expanding its AI-driven electronic health record (EHR) integration services nationwide. The company's innovative approach positions it for significant growth in digital healthcare transformation.
Cultural Differences Reveal Unique Sodium Intake Patterns Across Racial Groups
A new study explores how different racial and ethnic groups consume sodium, highlighting unique food sources and salt usage habits. The research provides insights into potential strategies for reducing sodium intake and improving heart health.
Unchained Leader Program Gains Global Recognition for Mental Health Support
Reuters is highlighting the Unchained Leader program, which helps men worldwide address mental health challenges through a comprehensive 90-day support system. The faith-based initiative focuses on holistic healing and personal transformation.
Innovative Animated Documentary 'Living with A Visionary' Explores Parkinson's Through Unique Visual Storytelling
Garden Shed Productions is creating an innovative animated documentary short that transforms a poignant memoir about caregiving and Parkinson's into a groundbreaking hand-animated film, utilizing specialized watercolor techniques to capture the emotional complexity of memory and hallucination.
Shala Hormone Health Revamps Affiliate Program, Empowering Women's Wellness Community
Shala Hormone Health has relaunched its affiliate program, offering women up to 30% commission while providing comprehensive support and training for wellness-focused social selling. The program aims to create meaningful income opportunities aligned with holistic health principles.
FDA Updates COVID-19 Vaccination Strategy, GeoVax Poised to Meet Targeted Needs
The FDA has shifted to a risk-based COVID-19 vaccination approach, prioritizing protection for vulnerable populations. GeoVax's multi-antigen vaccine GEO-CM04S1 appears well-positioned to address these evolving public health requirements.